GeneWEAVE BioSciences Inc.

It appears that the biopharmaceutical industry is on its way to not only beat but completely demolish prior venture capital fundraising records, based on totals for the first half of 2020 reported in

Several recent events highlight an increase in the pace of innovation in rapid infectious disease testing. In July, Accelerate Diagnostics Inc. filed a De Novo request to the US Food and Drug Ad

The other shoe finally dropped in late May when bacteria resistant to antibiotics of last resort was found in a person in the US. While this particular patient recovered, it was a harbinger of a day w

Many of the fundamental trends and issues we’ve spotted in the past several years – the degree of leverage the diagnostics industry can gain from the integration of companion diagnostics into pharma’s